Clinical trials
catalyst calendar across sponsors →Studies where COLL is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 1 with posted results
Held by 12 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Qube Research & Technologies Ltd, D. E. Shaw & Co., Inc., MARSHALL WACE, LLP, +7 more) · FINRA short interest 17.4 days to cover (settled 2026-07-31) · government filings 180d: 0 congress / 2 executive
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)NCT01685684results2017-02-23Change in Average Pain Intensity Measured by the Change in Pain Intensity-Numeric Rating Scale (PI-NRS) Scores From Randomization Baseline to Week 12 of the Double-blind Maintenance PhaseRandomized · Double-masked · Treatment | Phase 3 | Completed | Drug: Oxycodone DETERx, Placebo | Chronic Low Back Pain | 740 | Jun 2014actual | 2020-10-19 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19